Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY – Get Free Report)’s share price gapped up prior to trading on Tuesday. The stock had previously closed at $6.75, but opened at $7.17. Coloplast A/S shares last traded at $7.14, with a volume of 62,691 shares trading hands.
Coloplast A/S Stock Performance
The company has a market cap of $16.38 billion, a P/E ratio of 38.27, a price-to-earnings-growth ratio of 2.56 and a beta of 0.21. The company has a quick ratio of 0.94, a current ratio of 1.56 and a debt-to-equity ratio of 1.51. The stock has a 50 day moving average price of $6.82 and a two-hundred day moving average price of $6.81.
Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) last released its earnings results on Tuesday, November 3rd. The company reported $0.09 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.09. Coloplast A/S had a return on equity of 39.27% and a net margin of 9.68%. On average, research analysts predict that Coloplast A/S Sponsored ADR will post 0.40 earnings per share for the current fiscal year.
About Coloplast A/S
Coloplast A/S is a Denmark-based medical technology company that develops, manufactures and markets products designed to help people manage intimate health conditions. Its core businesses include ostomy care, continence care, wound and skin care, and interventional urology. The company’s products are used by patients and healthcare professionals in hospitals, clinics and home-care settings.
Coloplast was founded in Denmark in 1957 after nurse Elise Sørensen helped develop an adhesive ostomy bag for her sister, who had undergone surgery.
Featured Articles
- Five stocks we like better than Coloplast A/S
- MicroVision Pivots: Mapping New Ground Beyond Auto
- Are the Fears Around Alphabet’s Search Slowdown Warranted?
- Streaming Success: Fox Corp Channels Tubi For Q1 Earnings Beat
- Caterpillar’s Sell-Off: Is the Market Missing Its AI Power Play?
Receive News & Ratings for Coloplast A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coloplast A/S and related companies with MarketBeat.com's FREE daily email newsletter.
